|
![]() |
|||
|
||||
OverviewMonitoring the safety of medicine use in children is of paramount importance since during the clinical development of medicines only limited data on this aspect are generated through clinical trials. Use of medicines outside the specifications described in the licence - in terms of formulation, indications, contraindications or age - constitutes off-label and off-licence use and these are a major area of concern. Promoting Safety of Medicines for Children's is intended to improve awareness of medicine safety issues among those with an interest in the safety of medicines in children and to provide guidance on effective systems for monitoring medicine safety in the paediatric populations. This publication will be of interest to all health care professionals, medicine regulatory authorities, pharmacovigilance centres, academia, the pharmaceutical industry, and policy-makers. Full Product DetailsAuthor: World Health Organization(WHO)Publisher: World Health Organization Imprint: World Health Organization Dimensions: Width: 24.00cm , Height: 0.80cm , Length: 16.00cm Weight: 0.159kg ISBN: 9789241563437ISBN 10: 9241563435 Pages: 59 Publication Date: 21 September 2007 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of Contents1 - Introduction; 2 - Current Situation; 3 - The Essential Role of Safety Monitoring in the Life-cycle of a Medicine; 4 - Medication Errors; 5 - Primary Responsibility of Stakeholders; 6 - Guidance: Measures to be Taken; 7 - Measures to be Taken by WHO; Annex 1 - Pharmacovigilance Methods; Annex 2 - Recent Information on Adverse Reactions to Marketed Medicines in Children.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |